Risk of Malignancy in Thyroid Incidentaloma is Not Increased in Overweight or Obese Patients, but in Young Patients

References

• Park HS, Park CY, Oh SW, and Yoo HJ: Prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev 9, 104–107, 2008. doi: 10.1111/j.1467-789X.2007.00421.x
   PubMed Web of Science ®Google Scholar
• Malnick SD and Knobler H: The medical complications of obesity. QJM 99, 565–579, 2006. doi: 10.1093/qjmed/hcl085
   PubMed Web of Science ®Google Scholar
• Vucenik I and Stains JP: Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci 1271, 37–43, 2012. doi: 10.1111/j.1749-6632.2012.06750.x
   PubMed Web of Science ®Google Scholar
• van Kruijsdijk RC, van der Wall E, and Visseren FL: Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 18, 2569–2578, 2009. doi: 10.1158/1055-9965.EPI-09-0372
   PubMed Web of Science ®Google Scholar
• Jung K-W, Won Y-J, Kong H-J, Oh C-M, Cho H, et al.: Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 47, 127, 2015.
   PubMedGoogle Scholar
• Davies L and Welch HG: Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167, 2006. doi: 10.1001/jama.295.18.2164
   PubMed Web of Science ®Google Scholar
• Jin J and McHenry CR: Thyroid incidentaloma. Best Pract Res Clin Endocrinol Metab 26, 83–96, 2012. doi: 10.1016/j.beem.2011.06.004
   PubMed Web of Science ®Google Scholar
• Tan GH and Gharib H: Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126, 226–231, 1997.
   PubMed Web of Science ®Google Scholar
• Moon SH, Hyun SH, and Choi JY: Prognostic significance of volume-based PET parameters in cancer patients. Korean J Radiol 14, 1–12, 2013. doi: 10.3348/kjr.2013.14.1.1
   PubMed Web of Science ®Google Scholar
• Kim H, Kim SJ, Kim IJ, and Kim K: Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer—a large retrospective monocentric study. Onkologie 36, 260–264, 2013. doi: 10.1159/000350305
   PubMedGoogle Scholar
• Cibas ES and Ali SZ, Conference NCITFSotS: The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 132, 658–665, 2009. doi: 10.1309/AJCPPHLWMI3JV4LA
   PubMed Web of Science ®Google Scholar
• Simmonds M, Burch J, Llewellyn A, Griffiths C, Yang H, et al.: The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis. Health Technol Assess 19, 1–336, 2015. doi: 10.3310/hta19430
   PubMed Web of Science ®Google Scholar
• Bianchini F, Kaaks R, and Vainio H: Overweight, obesity, and cancer risk. Lancet Oncol 3, 565–574, 2002.
   PubMed Web of Science ®Google Scholar
• Barba C, Cavalli-Sforza T, Cutter J, and Darnton-Hill I: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163, 2004. doi: 10.1016/S0140-6736(03)15268-3
   PubMed Web of Science ®Google Scholar
• Kitahara CM, Platz EA, Freeman LEB, Hsing AW, Linet MS, et al.: Obesity and thyroid cancer risk among US men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 20, 464–472, 2011. doi: 10.1158/1055-9965.Epi-10-1220
   PubMed Web of Science ®Google Scholar
• Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, et al.: Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 40, 2041–2050, 2012.
   PubMed Web of Science ®Google Scholar
• Han JM, Kim TY, Jeon MJ, Yim JH, Kim WG, et al.: Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol 168, 879–886, 2013. doi: 10.1530/Eje-13-0065
   PubMed Web of Science ®Google Scholar
• Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, et al.: Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93, 1062–1067, 2005. doi: 10.1038/sj.bjc.6602819
   PubMed Web of Science ®Google Scholar
• Kim JY, Jung EJ, Park ST, Jeong SH, Jeong CY, et al.: Body size and thyroid nodules in healthy Korean population. J Korean Surg Soc 82, 13–17, 2012. doi: 10.4174/jkss.2012.82.1.13
   PubMedGoogle Scholar
• Iribarren C, Haselkorn T, Tekawa IS, and Friedman GD: Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 93, 745–750, 2001.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee CR, Ku CR, Kang SW, Jeong JJ, et al.: Association between obesity and BRAFV600E mutation status in patients with papillary thyroid cancer. Ann Surg Oncol 22 Suppl 3, S683–S690, 2015. doi: 10.1245/s10434-015-4765-z
   Google Scholar
• Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, et al.: Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol 162, 763–770, 2010. doi: 10.1530/EJE-09-0895
   PubMed Web of Science ®Google Scholar
• Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, et al.: Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol 94, 456–462, 2004. doi: 10.1016/j.ygyno.2004.05.006
   PubMed Web of Science ®Google Scholar
• Pak K, Cheon GJ, Lee KE, Park YJ, Choi HS, et al.: Incidental thyroid cancer detected by (18)F-FDG PET: does it have different clinicopathological features? Nucl Med Commun 35, 453–458, 2014. doi: 10.1097/MNM.0000000000000076
   PubMed Web of Science ®Google Scholar
• Lee SH, Han S, Lee HS, Chae SY, Lee JJ, et al.: Association between (18)F-FDG avidity and the BRAF mutation in papillary thyroid carcinoma. Nucl Med Mol Imaging 50, 38–45, 2016. doi: 10.1007/s13139-015-0367-8
   PubMed Web of Science ®Google Scholar